14 Years Surviving Stage 3 Cancer, Mrs. Soenaringsih Demonstrates That If You Want to Be Quickly Free from Cancer, Undergo Standard Therapy, and Immediately Use ECCT
Diagnosed in 2012 with stage 3 invasive lobular breast carcinoma, Mrs. Soenaringsih wanted to pursue every reasonable option rather than rely on one treatment. Her test results included ER-negative, PR-positive and HER2-negative markers. She underwent surgery and chemotherapy, took prescribed hormone-lowering medicine and also began using ECCT early in its development.
Almost fourteen years later, she continues taking anti-hormone medication and using ECCT. The article describes her as healthy and active at nearly eighty, with few of the long-term medication effects often discussed in such cases. Earlier heart enlargement and lung infiltrates were reported to be absent on later examinations.
She still travels alone by bus between Semarang and Jakarta, leads a church choir of about twenty people, teaches children music and rides her motorcycle around the hills of Semarang.